Review Article

Inflammation Induced by Perfluorocarbon Liquid: Intra- and Postoperative Use

Table 2

PFCLs used as short-term tamponade [24, 2729].

PFCLPathologyTamponade timeFollow-upStudyResultsInflammation

C8F18Inferior RD with PVR
7 days to air, C3F8, or silicone oil14 monthsCase series

(Drury and Bourke 2011) [24]
Primary reattachment after PFCL and tamponade removal 76%
VA improvement 65%
VA stable 18%
Cataract 60%
Macular changes 12%
Inflammation 6%
IOP > 21 29%
Retained PFCL 24%
Iris 6 months after PFCL removal

C8F18RD with giant retinal tear
7–5 days to SF6, C3F8, or silicone oil24.5 monthsCases series

(Sirimaharaj et al. 2005) [27]
Primary reattachment after PFCL and tamponade removal 80.6%
VA improvement 54.8%
VA stable 32.3%
Cataract 80.5%
Macular changes 0%
Inflammation 0%
Glaucoma 4.8%
Retained PFCL 0%

C8F18RD with giant retinal tear and PVR5 days to C3F8 or silicone oil16 monthsCases series

(Ventura et al. 2007) [28]
Primary reattachment after PFCL and tamponade removal 80%
VA improvement 50%
VA stable 20%
Inflammation 30%
30% hypotony with anterior chamber and vitreous cell reaction

C10F18RD with GRT and PVR5 days to fluid18 monthsCases series

(Bottoni et al. 1994) [29]
Primary reattachment after PFCL removal 82%
VA 64% > 20/40
High IOP 30%
Inflammation in AC 28%
MER 9%
ERG normal
28% AC flare or fibrin reaction